ACC
TEVA icon

Accident Compensation Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Accident Compensation Corp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-29,184
Closed -$499K – 133
2018
Q1 		$499K Sell
29,184
-27,300
-48% -$533K 0.15% 99
2017
Q4 		$1.07M Sell
56,484
-28,500
-34% -$429K 0.3% 84
2017
Q3 		$1.5M Sell
84,984
-19,600
-19% -$441K 0.41% 79
2017
Q2 		$3.47M Sell
104,584
-6,000
-5% -$186K 0.94% 41
2017
Q1 		$3.55M Sell
110,584
-19,700
-15% -$672K 0.9% 44
2016
Q4 		$4.72M Buy
130,284
+3,800
+3% +$152K 1.24% 30
2016
Q3 		$5.82M Buy
126,484
+6,100
+5% +$318K 1.54% 15
2016
Q2 		$6.05M Buy
120,384
+7,254
+6% +$386K 1.66% 16
2016
Q1 		$6.05M Buy
113,130
+11,000
+11% +$645K 1.68% 17
2015
Q4 		$6.7M Buy
+102,130
New +$6.31M 2.08% 10

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Accident Compensation Corp's TEVA Position: Q2 2018 in Review

Accident Compensation Corp sold out of Teva Pharmaceuticals (TEVA) in Q2 2018, closing a stake of 29,184 shares — an estimated $499K sold.

Accident Compensation Corp first reported a position in TEVA in Q4 2015 and held it in 10 quarters. The position peaked at $6.7M in Q4 2015. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

  • Accident Compensation Corp reported no remaining Teva Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Accident Compensation Corp sold 29,184 Teva Pharmaceuticals shares in Q2 2018, an estimated $499K.
  • Accident Compensation Corp first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 10 quarters.
  • Accident Compensation Corp's Teva Pharmaceuticals position peaked at $6.7M in Q4 2015.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2018.

Based on Accident Compensation Corp's 13F filing for Q2 2018, filed 14 Aug 2018.